OECD Health Statistics

OECD Health Statistics
Name	OECD Health Statistics
Established	1960s
Type	International statistical database
Owner	Organisation for Economic Co-operation and Development

OECD Health Statistics provides comparative health data for OECD members and partner countries, compiling indicators on health status, health resources, health spending, and health care activities. It is maintained by the Organisation for Economic Co-operation and Development and is widely used by analysts at the World Health Organization, World Bank, European Commission, and national ministries such as Ministry of Health (France), Department of Health and Human Services (United States), and National Health Service (England). Policymakers, academics, and journalists from institutions including Harvard University, London School of Economics, Johns Hopkins University, Karolinska Institutet, and University of Toronto rely on it for cross-country comparisons, benchmarking, and research.

Overview

The database aggregates standardized indicators across OECD member states like United States, Japan, Germany, France, United Kingdom, Canada, Australia, Italy, Spain, and partner economies such as China, India, Brazil, South Africa, and Russia. It situates health measures alongside related work by United Nations, International Monetary Fund, European Central Bank, World Trade Organization, and regional organizations including European Union and African Union. The project grew from statistical programs tied to the post‑war reconstruction era and intergovernmental cooperation evident in documents linked to Treaty of Rome and later multilateral initiatives like the Bretton Woods Conference. Data are organized to enable comparisons that reflect policy reforms similar to those debated in forums like the G20 and G7 Summit.

Data Coverage and Indicators

Coverage spans demographic and outcome indicators such as life expectancy at birth, infant mortality, and disease-specific mortality for conditions referenced in classifications like the International Classification of Diseases; resource indicators including numbers of physicians, nurses, and hospital beds; and financing indicators covering total health expenditure, public and private spending, and out-of-pocket payments. Clinical activity measures include hospital discharges, surgical procedures, and pharmaceutical consumption mapped against regulatory frameworks like those from the European Medicines Agency and Food and Drug Administration. Preventive and behavioural indicators capture immunization rates, smoking prevalence, and obesity prevalence measured in surveys comparable to those of Eurostat and the Behavioral Risk Factor Surveillance System.

Methodology and Data Collection

The OECD employs standardized definitions, coding schemes, and collection protocols aligned with international standards such as the System of National Accounts, the International Classification of Functioning, Disability and Health, and guidelines promoted by the World Health Organization. Data are submitted by national statistical offices (e.g., Institut national de la statistique et des études économiques, U.S. Census Bureau, Statistisches Bundesamt), ministries like Ministry of Health (Japan), and agencies such as Centers for Disease Control and Prevention and Public Health England. The process includes validation, reconciliation of administrative and survey sources, and engagement with technical committees composed of experts from Organisation for Economic Co-operation and Development member delegations and partner research institutions such as OECD Health Division panels and academic collaborators from Imperial College London and University of Melbourne.

Access and Dissemination

Users access data through online platforms, downloadable datasets, and thematic publications coordinated with flagship reports analogous to those produced by Global Health Observatory, World Health Report, and regional analyses by European Observatory on Health Systems and Policies. Outputs include time series, country notes, and metadata used by outlets such as The Economist, Financial Times, New York Times, Le Monde, and research centers like RAND Corporation and Brookings Institution. Training and capacity building are delivered through workshops and partnerships with entities such as World Bank Institute and universities in programs affiliated with United Nations University.

Uses and Impact

The dataset informs national policy debates on financing reforms exemplified by discussions in parliaments such as the British House of Commons and the United States Congress, underpins comparative health system research published in journals like The Lancet, Health Affairs, and BMJ, and supports international monitoring for initiatives linked to the Sustainable Development Goals and global health security efforts connected to the Global Fund. It has been used in empirical studies at Massachusetts Institute of Technology and Stanford University to evaluate cost‑effectiveness, access equity, and the impact of aging populations on long‑term care systems like those in Sweden and Japan.

Criticisms and Limitations

Critiques focus on issues of comparability, timeliness, and granularity: indicators may reflect differing national accounting practices as debated in forums like G20, coding differences tied to revisions of the International Classification of Diseases, and delays in submission from statistical agencies such as Statistics Canada or Istat. Researchers at institutions including University College London and Yale University have highlighted limitations for subnational analysis, the challenge of capturing informal payments and private markets prominent in studies of India and Russia, and potential biases when administrative data miss marginalized populations documented in reports by Amnesty International and Human Rights Watch.

Category:International statistics